We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)'s share was trading at $605.39 as of 29th May. REGN’s trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance.
[caption id="attachment_1238816" align="aligncenter" width="768"]Regeneron’s latest earnings report was notably weak,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.